Normal levels of the antiprion proteins Btn2 and Cur1 cure most newly formed [URE3] prion variants

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 26, 2014, Pages

  Wickner, Reed B ^a   Bezsonov, Evgeny ^a   Bateman, David A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Bmh1; Prion seed sequestration; Sis1

Indexed keywords

AMYLOID; BTN2 PROTEIN; CUR1 PROTEIN; HOOK PROTEIN; HSP42P PROTEIN; NITROGEN; PRION PROTEIN; PROTEIN; UNCLASSIFIED DRUG; URE2P PROTEIN; URE3 PROTEIN;

AGGRESOME; ARTICLE; CATABOLISM; GOLGI COMPLEX; MUTANT; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE;

BMH1; PRION SEED SEQUESTRATION; SIS1;

AMINO ACID TRANSPORT SYSTEMS; GENE EXPRESSION REGULATION, FUNGAL; GENE KNOCKOUT TECHNIQUES; GLUTATHIONE PEROXIDASE; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; PLASMIDS; PRIONS; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84903725419     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409582111     Document Type: Article

References (63)

1. Aigle M, Lacroute F (1975) Genetical aspects of [URE3], a non-mitochondrial, cytoplasmically inherited mutation in yeast. Mol Gen Genet 136(4):327-335.
2. Wickner RB (1994) [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 264(5158):566-569.
3. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB (1999) Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283(5406):1339-1343.
4. Brachmann A, Baxa U, Wickner RB (2005) Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 24(17):3082-3092.
5. Cooper TG (2002) Transmitting the signal of excess nitrogen in Saccharomyces cerevisiae from the Tor proteins to the GATA factors: Connecting the dots. FEMS Microbiol Rev 26(3): 223-238.
6. Magasanik B, Kaiser CA (2002) Nitrogen regulation in Saccharomyces cerevisiae. Gene 290(1-2):1-18.
7. Schwimmer C, Masison DC (2002) Antagonistic interactions between yeast [PSI(+) ] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p. Mol Cell Biol 22(11):3590-3598.
8. McGlinchey RP, Kryndushkin D, Wickner RB (2011) Suicidal [PSI+] is a lethal yeast prion. Proc Natl Acad Sci USA 108(13):5337-5341.
9. Baxa U, et al. (2007) Characterization of β-sheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry 46(45):13149-13162.
10. Wickner RB, Shewmaker F, Kryndushkin D, Edskes HK (2008) Protein inheritance (prions) based on parallel in-register β-sheet amyloid structures. BioEssays 30(10):955-964.
11. Liebman SW, Chernoff YO (2012) Prions in yeast. Genetics 191(4):1041-1072.
12. Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997) Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147(2):507-519.
13. Sondheimer N, Lindquist S (2000) Rnq1: An epigenetic modifier of protein function in yeast. Mol Cell 5(1):163-172.
14. Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001) Prions affect the appearance of other prions: The story of [PIN(+) ]. Cell 106(2):171-182.
15. Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: A cellular response to misfolded proteins. J Cell Biol 143(7):1883-1898.
16. Wang Y, et al. (2009) Abnormal proteins can form aggresome in yeast: Aggresometargeting signals and components of the machinery. FASEB J 23(2):451-463.
17. Kryndushkin DS, Shewmaker F, Wickner RB (2008) Curing of the [URE3] prion by Btn2p, a Batten disease-related protein. EMBO J 27(20):2725-2735.
18. Kanneganti V, Kama R, Gerst JE (2011) Btn3 is a negative regulator of Btn2-mediated endosomal protein trafficking and prion curing in yeast. Mol Biol Cell 22(10):1648-1663.
19. Kryndushkin D, Ihrke G, Piermartiri TC, Shewmaker F (2012) A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity. Mol Microbiol 86(6):1531-1547.
20. Kaganovich D, Kopito R, Frydman J (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454(7208):1088-1095.
21. Chernoff YO, Derkach IL, Inge-Vechtomov SG (1993) Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr Genet 24(3):268-270.
22. Kochneva-Pervukhova NV, Poznyakovski AI, Smirnov VN, Ter-Avanesyan MD (1998) C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharomyces cerevisiae. Curr Genet 34(2): 146-151.
23. Specht S, Miller SBM, Mogk A, Bukau B (2011) Hsp42 is required for sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae. J Cell Biol 195(4):617-629.
24. Duennwald ML, Echeverria A, Shorter J (2012) Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. PLoS Biol 10(6):e1001346.
25. Malinovska L, Kroschwald S, Munder MC, Richter D, Alberti S (2012) Molecular chaperones and stress-inducible protein-sorting factors coordinate the spatiotemporal distribution of protein aggregates. Mol Biol Cell 23(16):3041-3056.
26. Schlumpberger M, Prusiner SB, Herskowitz I (2001) Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 21(20):7035-7046.
27. Masison DC, Wickner RB (1995) Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270(5233):93-95.
28. Lacroute F (1971) Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J Bacteriol 106(2):519-522.
29. Cox B, Ness F, Tuite M (2003) Analysis of the generation and segregation of propagons: entities that propagate the [PSI+] prion in yeast. Genetics 165(1):23-33.
30. Hall D, Edskes H (2004) Silent prions lying in wait: A two-hit model of prion/amyloid formation and infection. J Mol Biol 336(3):775-786.
31. Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442(7102):585-589.
32. Jung G, Masison DC (2001) Guanidine hydrochloride inhibits Hsp104 activity in vivo: A possible explanation for its effect in curing yeast prions. Curr Microbiol 43(1):7-10.
33. Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF (2001) The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 40(6):1357-1369.
34. Jung G, Jones G, Masison DC (2002) Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc Natl Acad Sci USA 99(15):9936-9941.
35. Ness F, Ferreira P, Cox BS, Tuite MF (2002) Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 22(15):5593-5605.
36. Higurashi T, Hines JK, Sahi C, Aron R, Craig EA (2008) Specificity of the J-protein Sis1 in the propagation of 3 yeast prions. Proc Natl Acad Sci USA 105(43):16596-16601.
37. Gardner RG, Nelson ZW, Gottschling DE (2005) Degradation-mediated protein quality control in the nucleus. Cell 120(6):803-815.
38. Heck JW, Cheung SK, Hampton RY (2010) Cytoplasmic protein quality control degradation mediated by parallel actions of the E3 ubiquitin ligases Ubr1 and San1. Proc Natl Acad Sci USA 107(3):1106-1111.
39. Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB (2005) Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci USA 102(30):10575-10580.
40. Kelly AC, Shewmaker FP, Kryndushkin D, Wickner RB (2012) Sex, prions, and plasmids in yeast. Proc Natl Acad Sci USA 109(40):E2683-E2690.
41. Edskes HK, McCann LM, Hebert AM, Wickner RB (2009) Prion variants and species barriers among Saccharomyces Ure2 proteins. Genetics 181(3):1159-1167.
42. Chen B, et al. (2010) Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 76(6):1483-1499.
43. Bateman DA, Wickner RB (2012) [PSI+] Prion transmission barriers protect Saccharomyces cerevisiae from infection: Intraspecies 'species barriers'. Genetics 190(2):569-579.
44. Bateman DA, Wickner RB (2013) The [PSI+] prion exists as a dynamic cloud of variants. PLoS Genet 9(1):e1003257.
45. Ghaemmaghami S, et al. (2003) Global analysis of protein expression in yeast. Nature 425(6959):737-741.
46. Pearce DA, Ferea T, Nosel SA, Das B, Sherman F (1999) Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat Genet 22(1):55-58.
47. Gasch AP, et al. (2000) Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 11(12):4241-4257.
48. Chattopadhyay S, Muzaffar NE, Sherman F, Pearce DA (2000) The yeast model for batten disease: Mutations in BTN1, BTN2, and HSP30 alter pH homeostasis. J Bacteriol 182(22):6418-6423.
49. Kama R, Robinson M, Gerst JE (2007) Btn2, a Hook1 ortholog and potential Batten disease-related protein, mediates late endosome-Golgi protein sorting in yeast. Mol Cell Biol 27(2):605-621.
50. Chattopadhyay S, Pearce DA (2002) Interaction with Btn2p is required for localization of Rsglp: Btn2p-mediated changes in arginine uptake in Saccharomyces cerevisiae. Eukaryot Cell 1(4):606-612.
51. Chattopadhyay S, Roberts PM, Pearce DA (2003) The yeast model for Batten disease: A role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1p. Biochem Biophys Res Commun 302(3):534-538.
52. Krämer H, Phistry M (1996) Mutations in the Drosophila hook gene inhibit endocytosis of the boss transmembrane ligand into multivesicular bodies. J Cell Biol 133(6): 1205-1215.
53. Malone CJ, et al. (2003) The C. elegans hook protein, ZYG-12, mediates the essential attachment between the centrosome and nucleus. Cell 115(7):825-836.
54. Szebenyi G, et al. (2007) Hook2 contributes to aggresome formation. BMC Cell Biol 8:19.
55. Krämer H, Phistry M (1999) Genetic analysis of hook, a gene required for endocytic trafficking in drosophila. Genetics 151(2):675-684.
56. Maldonado-Báez L, Cole NB, Krämer H, Donaldson JG (2013) Microtubule-dependent endosomal sorting of clathrin-independent cargo by Hook1. J Cell Biol 201(2): 233-247.
57. Chernoff YO, Newnam GP, Kumar J, Allen K, Zink AD (1999) Evidence for a protein mutator in yeast: Role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion. Mol Cell Biol 19(12):8103-8112.
58. Chacinska A, et al. (2001) Ssb1 chaperone is a [PSI+] prion-curing factor. Curr Genet 39(2):62-67.
59. Wickner RB, et al. (2013) Amyloids and yeast prion biology. Biochemistry 52(9): 1514-1527.
60. Winzeler EA, et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285(5429):901-906.
61. Sherman F (1991) Getting Started with Yeast. Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, eds Guthrie C, Fink GR (Academic, San Diego) , Vol 194, pp 3-21.
62. Sikorski RS, Hieter P (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122(1):19-27.
63. Christianson TW, Sikorski RS, Dante M, Shero JH, Hieter P (1992) Multifunctional yeast high-copy-number shuttle vectors. Gene 110(1):119-122.